Mitoxantrone (novantrone): a review of experimental and early clinical studies.
D000818:Animals; D000880:Anthraquinones / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D007364:Intercalating Agents / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy; D008942:Mitoxantrone; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced
D000880:Anthraquinones; D000970:Antineoplastic Agents; D007364:Intercalating Agents; D004317:Doxorubicin; D008942:Mitoxantrone